Targacept, Inc.

Targacept, Inc.

Biotechnology Research 100 North Main Street 31 employees
Employees
31
Contacts
1
Emails
1

Targacept, Inc. Overview

Headquarters
100 North Main Street
Website
targacept.com
Industry
Biotechnology Research
Employees
31
Founded
1997
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Targacept, Inc.

Targacept is developing a diverse pipeline of innovative NNR Therapeutics™ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, unique proteins that regulate vital biological functions that are impaired in various disease states. Targacept’s clinical pipeline includes multiple Phase 2 product candidates, all representing first-in-class opportunities. Targacept leverages its scientific leadership and diverse pipeline to attract significant collaborations with global pharmaceutical companies. For more information, please visit www.targacept.com.

Targacept, Inc. Contact Details

People in AeroLeads
1
With contact data
1
Email contacts
1
100.0% coverage

Targacept, Inc. Org Chart

Sample employees and titles
Name Title Contact
Julia Brown
Email

Employees by Management Level

Individual contributor 6 profiles
Manager 4 profiles
Senior / Lead 3 profiles
Director 2 profiles
Executive 1 profile
VP / Head 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 7 7 5
Executive 3 3 1
Finance 2 2 2
Healthcare 2 2 0
IT 1 1 0

Targacept, Inc. Tech Stack

Data / AI 5 profiles

Compare Similar Companies to Targacept, Inc.